Cuscó Ivon, López Eva, Soler-Botija Carolina, Jesús Barceló María, Baiget Montserrat, Tizzano Eduardo F
Hospital de Sant Pau, Genetics and Research Institute, Barcelona, Spain.
Hum Mutat. 2003 Aug;22(2):136-43. doi: 10.1002/humu.10245.
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder caused by mutations in the SMN1 (survival motor neuron) gene. It is classified by age of onset and maximal motor milestones achieved in type I, II, and III (severe, intermediate, and mild form, respectively). Of 369 unrelated SMA patients who were investigated for homozygous deletions in the SMN1 gene, 18 patients (4.8%) revealed at least one copy of exon 7. A 4-bp deletion in exon 3 (c.399_402delAGAG) was detected in 15 patients from 10 families. This mutation was associated with a large spectrum of phenotypes from type I to asymptomatic patients. Five patients from two consanguineous families were homozygous for the mutation with diverse mild phenotypes. Determination of the SMN2 copy number showed that the presence of two or three copies generally correlated with a better evolution. RT-PCR studies of SMN transcripts in control and patients with the same SMN2 copy number showed that the full-length/Delta7 ratio is influenced by the SMN1 genotype although it seems independent of the SMN2 copy number. Moreover, protein analysis in these patients showed a reduction in SMN protein in compound heterozygous patients (c.399_402delAGAG/deletion) when compared with homozygous c.399_402delAGAG/c.399_402delAGAG patients. Microsatellite DNA markers flanking the SMA locus revealed the occurrence of the 4-bp deletion in the background of the same haplotype, suggesting that a single mutational event was involved in the 10 families. The geographic origins of ancestors point to a founder effect from the south and east of Spain. The c.399_402delAGAG, which is to date unique to the Spanish population, constitutes the most frequently found subtle mutation in SMA. Hum Mutat 22:136-143, 2003.
脊髓性肌萎缩症(SMA)是一种常染色体隐性神经肌肉疾病,由SMN1(存活运动神经元)基因突变引起。它根据发病年龄和达到的最大运动里程碑分为I型、II型和III型(分别为重度、中度和轻度形式)。在369名接受SMN1基因纯合缺失调查的非相关SMA患者中,18名患者(4.8%)显示至少有一个外显子7拷贝。在来自10个家庭的15名患者中检测到外显子3中的一个4碱基缺失(c.399_402delAGAG)。该突变与从I型到无症状患者的广泛表型相关。来自两个近亲家庭的5名患者为该突变的纯合子,具有不同的轻度表型。SMN2拷贝数的测定表明,两个或三个拷贝的存在通常与更好的病情发展相关。对具有相同SMN2拷贝数的对照和患者进行SMN转录本的RT-PCR研究表明,全长/Delta7比值受SMN1基因型影响,尽管它似乎与SMN2拷贝数无关。此外,这些患者的蛋白质分析表明,与纯合子c.399_402delAGAG/c.399_402delAGAG患者相比,复合杂合子患者(c.399_402delAGAG/缺失)的SMN蛋白减少。SMA基因座两侧的微卫星DNA标记显示在相同单倍型背景下出现了4碱基缺失,表明10个家庭涉及单一突变事件。祖先的地理起源表明来自西班牙南部和东部的奠基者效应。c.399_402delAGAG是迄今为止西班牙人群特有的,是SMA中最常见的细微突变。《人类突变》2003年第22卷:136 - 143页